Eton Pharmaceuticals (ETON) Stock Insights

ETON price $51.80 +0.64 +1.25%

Ticker
ETON
Price
$51.80
Change
+0.64 +1.25%
Market cap ?
$1.48B
P/E ?
107.89
Forward P/E ?
47.66
Dividend yield ?
0.00%
Beta ?
0.90
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Financials

201720182019202020212022202320242025
00959000390002183200021251000316420003901100079950000

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate…

Fair value

ETON fair value $35.52. Price $51.80. Price is 46% above fair value.

Above fair value, and more expensive than usual. A larger premium than on 64% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Average free cash flow, last three years 5.72M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.25% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 28.58M. Net debt 5.08M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare ETON

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—0.31—41.98M
2026-08-130.350.1937.59M27.11M
2026-05-140.050.1024.27M22.31M
2026-03-190.050.1221.28M19.98M
2025-11-06-0.070.1622.46M20.47M
2025-08-07-0.10-0.0118.93M20.47M
2025-05-130.070.0917.28M15.13M
2025-03-18-0.02-0.0211.65M14.33M
2024-11-120.020.0010.32M10.53M
2024-08-08-0.12-0.079.07M9.69M
2024-05-09-0.03-0.077.97M8.80M
2024-03-14-0.09-0.047.31M7.70M
2023-11-09-0.02-0.107.03M6.26M
2023-08-100.15-0.0912.00M10.09M
2023-05-11-0.10-0.145.30M6.51M
2023-03-160.040.018.50M4.56M
2022-11-10-0.12-0.153.22M3.05M
2022-08-11-0.06-0.017.36M7.80M
2022-05-12-0.21-0.082.18M2.04M
2022-03-160.040.196.09M—
2021-11-15-0.24-0.14775.00K663.96K
2021-08-16-0.08-0.143.07M4.76M
2021-05-130.190.1911.90M12.05M
2021-03-16-0.32-0.2681.00K—
2020-11-12-0.31-0.26161.00K—
2020-08-12-0.23-0.2820.00K22.61K
2020-05-14-0.50-0.2499.00K66.83K
2020-03-05-0.15-0.29459.00K795.60K
2019-11-14-0.28-0.23—446.43K
2019-08-06-0.18-0.30—777.78K
2019-05-07-0.42—500.00K—
2019-03-25-2.24———
2018-12-20-0.52———
2018-06-30-0.55———
2018-03-31-0.54———
2017-12-31-2.01———
2017-09-30-0.50———
2017-06-30-0.69———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-06Krempa DavidSell4.17K$55.07229.41K
2026-10-02Krempa DavidBuy10.52K——
2026-10-02Krempa DavidSell10.52K——
2026-08-28MAIER PAUL VBuy12.50K$7.3191.38K
2026-08-28MAIER PAUL VBuy12.50K$7.3191.38K
2026-08-28MAIER PAUL VBuy50.00K$3.78189.00K
2026-08-28MAIER PAUL VSell36.39K$58.642.13M
2026-08-28MAIER PAUL VSell13.48K$60.21811.93K
2026-08-28MAIER PAUL VSell128$61.777.91K
2026-08-28MAIER PAUL VSell50.00K$3.78189.00K
2026-08-24Krempa DavidSell25.00K$7.31182.75K
2026-08-24Krempa DavidBuy25.00K$7.31182.75K
2026-08-24Krempa DavidSell25.00K$65.071.63M
2026-08-20BRYNJELSEN SEANSell47.31K$60.172.85M
2026-08-20BRYNJELSEN SEANSell36.37K$61.112.22M
2026-08-20BRYNJELSEN SEANSell7.34K$62.12456.09K
2026-08-19BRYNJELSEN SEANSell8.98K$62.65562.47K
2026-07-31Radosavljevic DankaOther0——
2026-07-31Radosavljevic DankaOther31.51K$15.47487.43K
2026-07-31Radosavljevic DankaOther7.19K——
2026-07-31Radosavljevic DankaOther14.32K$13.00186.12K
2026-07-31Radosavljevic DankaOther10.00K$14.68146.80K
2026-07-31Radosavljevic DankaOther92.99K$4.42411.03K
2026-07-31Radosavljevic DankaOther10.00K$4.7447.40K
2026-07-31Radosavljevic DankaOther42.22K$3.47146.52K
2026-07-31Radosavljevic DankaOther35.00K$8.61301.35K
2026-07-31Radosavljevic DankaOther60.00K$3.58214.80K
2026-07-31Radosavljevic DankaOther18.74K$1.3825.86K
2026-07-31Radosavljevic DankaOther128.99K——
2026-07-31CASAMENTO CHARLES JBuy10.00K——
2026-07-31Matthews Judith M.Buy32.25K——
2026-07-31Erdogan-Trinkaus IpekBuy80.00K——
2026-07-31BRYNJELSEN SEANBuy128.99K——
2026-07-31Krempa DavidBuy128.99K——
2026-07-31MAIER PAUL VBuy10.00K——
2026-07-31RIEDEL NORBERT GBuy10.00K——
2026-07-31Adams Jennifer McKieBuy10.00K——
2026-07-14Opaleye Management Inc.Sell15.00K$37.54563.15K
2026-07-14Opaleye Management Inc.Sell13.31K$37.54499.89K
2026-07-14Opaleye Management Inc.Sell15.00K$37.54563.15K
2026-07-14Opaleye Management Inc.Sell13.31K$37.54499.89K
2026-07-14BRYNJELSEN SEANBuy200.00K$1.37274.00K
2026-07-14BRYNJELSEN SEANBuy200.00K$1.37274.00K
2026-07-12BRYNJELSEN SEANBuy27.50K——
2026-07-12BRYNJELSEN SEANSell27.50K——
2026-07-12Krempa DavidBuy10.00K——
2026-07-12Krempa DavidSell10.00K——
2026-07-07Opaleye Management Inc.Sell20.00K$38.37767.46K
2026-07-07Opaleye Management Inc.Sell6.68K$38.37256.52K
2026-07-06Opaleye Management Inc.Sell10.00K$38.00380.00K
2026-07-02Opaleye Management Inc.Sell65.00K$37.392.43M
2026-07-02Opaleye Management Inc.Sell25.00K$37.39934.63K
2026-06-26Krempa DavidBuy10.00K——
2026-06-17Adams Jennifer McKieBuy50.00K$3.78189.00K
2026-06-17Adams Jennifer McKieSell50.00K$3.78189.00K
2026-06-17Adams Jennifer McKieSell50.00K$32.481.62M
2026-06-01Matthews Judith M.Other37.00K$26.05963.85K
2026-05-28BRYNJELSEN SEANSell119.85K$31.883.82M
2026-05-28BRYNJELSEN SEANSell148$32.674.84K
2026-05-27Krempa DavidSell7.20K$3.5825.79K
2026-05-27Krempa DavidBuy7.20K$3.5825.79K
2026-05-27Krempa DavidBuy12.48K$1.3717.09K
2026-05-27Krempa DavidSell19.68K$31.47619.37K
2026-05-27Krempa DavidSell12.48K$1.3717.09K
2026-05-26Krempa DavidBuy12.52K$1.3717.16K
2026-05-26Krempa DavidBuy25.00K$1.3834.50K
2026-05-26Krempa DavidSell37.52K$31.491.18M
2026-05-26Krempa DavidSell12.52K$1.3717.16K
2026-05-26Krempa DavidSell25.00K$1.3834.50K
2026-05-22Krempa DavidSell30.59K$3.58109.52K
2026-05-22Krempa DavidBuy30.59K$3.58109.52K
2026-05-22Krempa DavidSell32.96K$33.221.10M
2026-05-22Krempa DavidSell9.31K$33.88315.59K
2026-05-22Krempa DavidSell519$35.0018.16K
2026-04-21RIEDEL NORBERT GBuy19.66K$8.61169.23K
2026-04-21RIEDEL NORBERT GBuy12.50K$7.3191.38K
2026-04-21RIEDEL NORBERT GSell19.66K$8.61169.23K
2026-04-21RIEDEL NORBERT GSell12.50K$7.3191.38K
2026-02-03RIEDEL NORBERT GBuy30.00K$4.42132.60K
2026-02-03RIEDEL NORBERT GSell30.00K$4.42132.60K
2026-01-14Krempa DavidSell1.94K$15.6230.33K
2026-01-14Gruber James R.Sell2.29K$15.4735.47K
2026-01-12RIEDEL NORBERT GBuy7.76K——
2026-01-12RIEDEL NORBERT GBuy12.20K$15.47188.67K
2026-01-12Adams Jennifer McKieBuy7.76K——
2026-01-12Adams Jennifer McKieBuy12.20K$15.47188.67K
2026-01-12CASAMENTO CHARLES JBuy7.76K——
2026-01-12CASAMENTO CHARLES JBuy12.20K$15.47188.67K
2026-01-12MAIER PAUL VBuy7.76K——
2026-01-12MAIER PAUL VBuy12.20K$15.47188.67K
2026-01-12Erdogan-Trinkaus IpekBuy25.86K——
2026-01-12Erdogan-Trinkaus IpekBuy40.66K$15.47628.93K
2026-01-12BRYNJELSEN SEANBuy100.52K——
2026-01-12BRYNJELSEN SEANBuy158.05K$15.472.44M
2026-01-12Krempa DavidBuy25.86K——
2026-01-12Krempa DavidBuy40.66K$15.47628.93K
2026-01-12Gruber James R.Buy25.86K——
2026-01-12Gruber James R.Buy40.66K$15.47628.93K
2026-01-01BRYNJELSEN SEANSell5.01K$15.3977.18K
2025-12-12Erdogan-Trinkaus IpekSell85$16.901.44K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 172, holders +51 vs prior quarter. Ownership 72.51%.

HolderSharesChangeChange %Value
OPALEYE MANAGEMENT INC.2.86M00.00%103.53M
ECOR1 CAPITAL, LLC2.17M00.00%78.62M
BLACKROCK, INC.1.90M178.55K+10.40%68.63M
NANTAHALA CAPITAL MANAGEMENT, LLC1.18M00.00%42.57M
VANGUARD CAPITAL MANAGEMENT LLC976.57K-17.52K-1.76%35.35M
MORGAN STANLEY767.97K290.01K+60.68%27.80M
STATE STREET CORP701.79K171.57K+32.36%25.40M
GEODE CAPITAL MANAGEMENT, LLC652.30K74.64K+12.92%23.62M
OBERWEIS ASSET MANAGEMENT INC/501.60K62.30K+14.18%18.16M
NATIONAL PHILANTHROPIC TRUST492.11K00.00%17.81M
WESTSIDE INVESTMENT MANAGEMENT, INC.431.16K-36.76K-7.86%15.61M
PILLSBURY LAKE CAPITAL LLC387.16K22.20K+6.08%14.02M
NUVEEN, LLC375.71K317.76K+548.33%13.60M
BNP PARIBAS FINANCIAL MARKETS322.47K20.36K+6.74%11.67M
WOODLINE PARTNERS LP310.88K140.18K+82.12%11.25M
THOMPSON SIEGEL & WALMSLEY LLC297.23K-108.86K-26.81%10.76M
NORTHERN TRUST CORP255.85K18.02K+7.58%9.26M
MARSHALL WACE, LLP249.18K166.46K+201.23%9.02M
PANORAMIC CAPITAL, LLC208.19K23.19K+12.54%7.54M
VANGUARD PORTFOLIO MANAGEMENT LLC194.59K42.84K+28.23%7.04M
JPMORGAN CHASE & CO191.63K21.76K+12.81%7.04M
D. E. SHAW & CO., INC.188.45K188.45KNew6.82M
JANE STREET GROUP, LLC185.70K168.40K+973.39%6.72M
LUMBARD & KELLNER, LLC175.91K-2-0.00%6.37M
CANNELL CAPITAL LLC170.75K-171.24K-50.07%6.18M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Eton Pharmaceuticals (ETON) Stock Insights

ETON$51.80+0.64 +1.25%

$1.48B

Market Cap

107.89

P/E

47.66

Forward P/E

—

Score

Price History